High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
Official title: Clinical and Electrophysiological Evaluation of the Effect of High-Intensity Peripheral Magnetic Stimulation in Traumatic Peripheral Nerve Injury: A Randomized, Double-Blind, Sham-Controlled Trial
Run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · NCT07705490 · Data updated 2026-11-12
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | June 2027 |
| Study ends | July 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07705490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-65 with unilateral traumatic peripheral nerve injury, DN4 ≥ 4, VAS ≥ 4, EMG-confirmed injury, and motor weakness (MRC < 5).
✕Probably not a fit
Patients with non-traumatic neuropathies, complete nerve injury, or contraindications to magnetic stimulation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, sham-controlled trial takes place at a single center and compares active high-intensity peripheral magnetic stimulation plus a standardized exercise program to sham stimulation plus the same exercise program in adults with unilateral traumatic peripheral nerve injury. Participants must have neuropathic pain, reduced muscle strength, and injury confirmation by EMG, with onset at least 3 months prior. The intervention consists of about 9 magnetic stimulation sessions over 3 weeks, delivered over the injured nerve, alongside daily personalized exercise therapy. Outcomes include pain, function, quality of life, and electrophysiological measures assessed at baseline, 4 weeks, and 8 weeks. Blinded assessors will evaluate outcomes to minimize bias.
Why it matters
Potential benefit: If successful, the approach could provide a non-invasive option to reduce pain and improve motor function after traumatic nerve injuries.
How similar studies have gone: Prior research on high-intensity magnetic stimulation for neuropathic pain and nerve rehabilitation has shown promise but is limited in traumatic nerve injury.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * Traumatic peripheral nerve injury * Unilateral traumatic peripheral neuropathy confirmed by electromyography (EMG) * Nerve injury occurring at least 3 months prior * Douleur Neuropathique 4 (DN4) score ≥ 4 * Visual Analog Scale (VAS) score ≥ 4 * Manual Muscle Testing score \< 5 * No analgesic use, or stable analgesic therapy for the past month (no dose changes) Exclusion Criteria: * Active infection or malignancy * Metal implant or shrapnel in the application area * Electronic implants (e.g., cardiac pacemaker, spinal cord stimulator, deep brain stimulator) * Central nervous system diseases * Non-traumatic causes of neuropathy (e.g., radiculopathy, diabetic neuropathy, entrapment neuropathies, HIV-related neuropathy, trigeminal neuralgia) * Complete nerve injury * Injury involving three or more peripheral nerves or plexus injury * History of peripheral nerve surgery or injection within the past 3 months * Active psychiatric illness * Coagulopathy
Where it's running
-
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Nurdan Korkmaz — Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Study coordinator: Hüseyin Anıl İnan, MD
- Email: dranilinan@gmail.com
- Phone: +905346159274
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided PRP Injections for Nerve Regeneration in Traumatic Peripheral Nerve Injury
This study tests whether ultrasound-guided platelet-rich plasma injections can help nerve regeneration in adults with traumatic peripheral nerve injuries.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
Hematological clues and how patients respond to nerve blocks for neuropathic pain
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
-
Cord plasma eye drops to treat neuropathic corneal pain
This trial will test whether cord plasma eye drops can reduce long-lasting nerve-related corneal pain in people with evidence of corneal nerve damage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.